Using the above methodology, we identified highly interconnected clusters of receptors and ligands, GDNF/GFRα1 binding to Ret or NCAM, which could be potential NBP therapy targets in CCH induced VD. The gene discussed is GFRA1; the disease is columnar cell hyperplasia of the breast.